Kinney Drugs files antitrust claims against Takeda, Endo, Par over Amitiza
MLex Summary: Kinney Drugs filed a complaint accusing Takeda Pharmaceuticals, Endo International, and Par Pharmaceutical of illegally delaying a generic competitor to Takeda branded anti-constipation drug Amitiza. The complaint alleges that...To view the full article, register now.
Already a subscriber? Click here to view full article